Connor, Clark & Lunn Investment Management (CC&L)
IDXX icon

Connor, Clark & Lunn Investment Management (CC&L)’s Idexx Laboratories IDXX Stock Holding History

Connor, Clark & Lunn Investment Management (CC&L)’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$400K Buy
+760
New +$426K ﹤0.01% 1442
2025
Q3 		– Sell
-969
Closed -$520K – 1604
2025
Q2 		$520K Buy
+969
New +$463K ﹤0.01% 1246
2024
Q2 		– Sell
-663
Closed -$358K – 1517
2024
Q1 		$358K Buy
+663
New +$362K ﹤0.01% 1208
2022
Q4 		– Sell
-3,716
Closed -$1.21M – 1314
2022
Q3 		$1.21M Sell
3,716
-7,013
-65% -$2.58M 0.01% 607
2022
Q2 		$3.76M Buy
10,729
+7,311
+214% +$2.98M 0.02% 362
2022
Q1 		$1.87M Buy
3,418
+1,252
+58% +$659K 0.01% 515
2021
Q4 		$1.43M Sell
2,166
-1,638
-43% -$1.03M 0.01% 608
2021
Q3 		$2.37M Sell
3,804
-23,015
-86% -$15.5M 0.01% 491
2021
Q2 		$16.9M Sell
26,819
-6,781
-20% -$3.74M 0.09% 184
2021
Q1 		$16.4M Buy
33,600
+12,960
+63% +$6.49M 0.09% 173
2020
Q4 		$10.3M Sell
20,640
-210
-1% -$94K 0.06% 223
2020
Q3 		$8.2M Buy
20,850
+8,025
+63% +$2.97M 0.05% 228
2020
Q2 		$4.23M Buy
12,825
+11,220
+699% +$3.25M 0.03% 326
2020
Q1 		$389K Sell
1,605
-2,845
-64% -$742K ﹤0.01% 752
2019
Q4 		$1.16M Buy
4,450
+1,550
+53% +$408K 0.01% 521
2019
Q3 		$789K Buy
2,900
+1,650
+132% +$459K 0.01% 590
2019
Q2 		$344K Buy
+1,250
New +$308K ﹤0.01% 797
2018
Q4 		– Sell
-2,050
Closed -$512K – 990
2018
Q3 		$512K Sell
2,050
-8,300
-80% -$2.01M ﹤0.01% 695
2018
Q2 		$2.26M Sell
10,350
-1,400
-12% -$288K 0.01% 449
2018
Q1 		$2.25M Sell
11,750
-100
-0.8% -$18.5K 0.01% 375
2017
Q4 		$1.85M Buy
11,850
+5,600
+90% +$881K 0.01% 428
2017
Q3 		$972K Buy
6,250
+3,850
+160% +$609K 0.01% 535
2017
Q2 		$387K Buy
+2,400
New +$390K ﹤0.01% 644

Other funds holding IDXX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

Connor, Clark & Lunn Investment Management (CC&L)'s IDXX Position: Q2 2026 in Review

Connor, Clark & Lunn Investment Management (CC&L) opened a new position in Idexx Laboratories (IDXX) in Q2 2026: 760 shares worth $400K. The stake represents ﹤0.01% of the portfolio and ranks #1442 among its holdings. This is a return to the name: Connor, Clark & Lunn Investment Management (CC&L) previously reported a position in IDXX as recently as Q2 2025.

Connor, Clark & Lunn Investment Management (CC&L) first reported a position in IDXX in Q2 2017 and has held it in 23 quarters since. The position peaked at $16.9M in Q2 2021. 1,306 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

  • Connor, Clark & Lunn Investment Management (CC&L) held 760 shares of Idexx Laboratories worth $400K as of Q2 2026.
  • Idexx Laboratories was a new Connor, Clark & Lunn Investment Management (CC&L) position in Q2 2026.
  • Idexx Laboratories made up ﹤0.01% of Connor, Clark & Lunn Investment Management (CC&L)'s portfolio in Q2 2026, its #1442 holding.
  • Connor, Clark & Lunn Investment Management (CC&L) first reported a position in Idexx Laboratories in Q2 2017 and has held it in 23 quarters since.
  • Connor, Clark & Lunn Investment Management (CC&L)'s Idexx Laboratories position peaked at $16.9M in Q2 2021.
  • 1,306 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on Connor, Clark & Lunn Investment Management (CC&L)'s 13F filing for Q2 2026, filed 13 Aug 2026.